At 29 days, the estimated cumulative rate of clinical resolution was 83% in tecovirimat recipients and 84% in those given placebo.
The test the US Centers for Disease Control and Prevention uses to identify clade I mpox cases is 'most likely not reliable' for detection of the substrain identified in the study, the authors say.
Another mpox study today showed that dose-sparing vaccine administration of the Jynneos vaccine appeared to have worked.
Receive the latest infectious disease information.
Cases in Europe have risen to 118, and the UK has now confirmed 78 monkeypox infections.
California and Washington state report their first cases, as CDC experts advise on what doctors should be alert for.
The CDC says many patients have a distinctive monkeypox rash around their genitals, and UK officials report 36 new infections.
At least 8 European countries and Canada, the US, and Australia have tallied cases.
As cases climb in several nations, an expert notes, "We are much more susceptible to poxviruses."
UK cases grow to 9, while Spain reports 23 suspected cases and Portugal 5 confirmed, 15 suspected.
Machine-learning models created by a National Institutes of Health (NIH)-supported research team can identify, with high accuracy, patients likely to have long COVID, according to a study yesterday in The Lancet Digital Health.
A randomized, controlled trial of 400 adults hospitalized for COVID-19–related respiratory failure suggests that awake prone positioning doesn't significantly reduce the need for endotracheal intubation at 30 days, but the authors caution that the effect size was imprecise and a therapeutic benefit cannot be ruled out.
In a study published in Open Forum Infectious Diseases, researchers showed canine olfaction—or dog sniffing—was both highly sensitive and specific when it came to identifying patients with COVID-19, even those who were asymptomatic or presymptomatic.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
